Skip to content

BIOHEMP INTERNATIONAL, INC.

company.status.inactive

CIK 1556416fmd_18TZAHW472VZ60QXJ91D881NK7Services · Services-Personal ServicesTemplate: Standard

Coverage: Sep 01, 2012 to May 31, 2019, 27 periods

Latest annual · FY2018

Millions
Net income
(0)

Latest quarter · Q3 FY2019

Millions
Net income
(0)
Open Financials

Key stats

Open Analysis

Compound annual growth

Net income, 5 yearsFY2013 to FY2018
n/m

BIOHEMP INTERNATIONAL, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2018FY2017ChangeSource
Net income-$45,201-$110,32310-Q 2019-04-23 · proof
Cash from operating activities-$84-$76,69910-K 2019-02-20 · proof
Total liabilities$236,665$191,548+23.6%10-Q 2019-02-27 · proof
What was BIOHEMP INTERNATIONAL, INC.'s net income in fiscal 2018?
BIOHEMP INTERNATIONAL, INC. reported net income of -$45,201 for fiscal 2018 (the year ended Aug 31, 2018), against -$110,323 the year before. Source: the 10-Q filed with the SEC on Apr 23, 2019 (restated). SEC
What was BIOHEMP INTERNATIONAL, INC.'s cash from operating activities in fiscal 2018?
BIOHEMP INTERNATIONAL, INC. reported cash from operating activities of -$84 for fiscal 2018 (the year ended Aug 31, 2018), against -$76,699 the year before. Source: the 10-K filed with the SEC on Feb 20, 2019. SEC
What are BIOHEMP INTERNATIONAL, INC.'s total liabilities?
As of Aug 31, 2018, BIOHEMP INTERNATIONAL, INC. reported total liabilities of $236,665, against $191,548 a year earlier (+23.6%). Source: the 10-Q filed with the SEC on Feb 27, 2019 (restated). SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1556416&period_type=annual&limit=5"

Information only, not investment advice.